Christopher Gibson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Christopher Gibson is Chief Executive Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.26 Million shares of RXRX, which is worth approximately $8.28 Million. The most recent transaction as insider was on Dec 13, 2021, when has been sold 100 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.26M
70.51%
3M change
13.68%
12M change
Total Value Held
$8.28 Million
Christopher Gibson Transaction History
CG
Christopher Gibson
Chief Executive Officer
Salt Lake City, UT